About the trial
The Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trial is a Sequential Multiple Assignment Randomised Trial (SMART) of nursing interventions to reduce pain associated with CIPN.
The SMART design of the CIPN clinical trial allows for the interventions to be adjusted based on participants’ responses to treatment.
The Australian Clinical Trials Consumer Guide to Clinical Trials states that clinical trials are medical research studies that aim to find a better way to manage a particular disease. The purpose of a clinical trial is to evaluate new approaches to learn how people respond to them and what side effects might occur as a result. Clinical trials are considered to be part of best practice medicine and are one of many options for treatment of a disease or illness.
The Australian Government National Health and Medical Research Council (NHMRC) website includes information for consumers about clinical trials including phases of clinical trials, how clinical trials work, who can be part of a clinical trial and types of clinical trials. To find out more about how clinical trials work, see NHMRC Australian Clinical Trials.
Referring your patients
Health professionals treating patients with chemotherapy induced peripheral neuropathy are encouraged to refer them to our clinical trial. If you would like more information, we can provide:
- detailed information for prospective study participants
- flyers for display in your clinic or office
- a call from a member of the research team to discuss the suitability of individual patients for the clinical trial, or any other questions you have about our research
Please contact us on 0412 009 133 or email email@example.com to request these.